China Medical Financials

China Medical Stock Summary

China Medical competes with Takeda Pharmaceutical, Shionogi, Dr Reddys, Superior Plus, and NMI Holdings. China Medical System Holdings Limited, an investment holding company, produces medicines and markets, promotes, and sells drugs in the Peoples Republic of China. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited. CHINA M operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3600 people.

China Medical Key Financial Ratios

There are many critical financial ratios that China Medical's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that China Medical System reports annually and quarterly.

China Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining China Medical's current stock value. Our valuation model uses many indicators to compare China Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across China Medical competition to find correlations between indicators driving China Medical's intrinsic value. More Info.China Medical System is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.54  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for China Medical System is roughly  1.84 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the China Medical's earnings, one of the primary drivers of an investment's value.

China Medical System Systematic Risk

Along with financial statement analysis, the daily predictive indicators of China Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of China Medical System. We use our internally-developed statistical techniques to arrive at the intrinsic value of China Medical System based on widely used predictive technical indicators. In general, we focus on analyzing China Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build China Medical's daily price indicators and compare them against related drivers.

When running China Medical's price analysis, check to measure China Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy China Medical is operating at the current time. Most of China Medical's value examination focuses on studying past and present price action to predict the probability of China Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move China Medical's price. Additionally, you may evaluate how the addition of China Medical to your portfolios can decrease your overall portfolio volatility.